During our screening search for antifungal antibiotics, Rhodopeptins were isolated from the bacterial pellet of Rhodococcus sp. Mer-NICBS.^Their structures were determined as novel cyclic tetrapeptides composed of a lipophilic /?-amino acid (abbreviated as /JAA) and three usual a-amino acids.2)
Because they have interesting biological activity and unique structures, we attempted to establish the synthetic method which could be applied for studies on the structureactivity relationship of rhodopeptin derivatives. In this paper, we report the syntheses of rhodopeptin analogues.
Chemi stry
Wechose the rhodopeptin B5 analogue that was composed of Gly, Lys, Val and 3-aminododecanoic acid (abbreviated as n-Cn-PAA) as the synthetic target shown in Fig.  1 . «-C12-/?AA was selected as the /3AA moiety in consider- pp.710 -720 ation of the following two points: (i) it will be convenient to synthesize /3AA with no second chiral center in the side chain; (ii) the target analogues will be interested in the biological activities, because the side chain of the /JAAs composing naturally occurring rhodopeptins was isolated as an iso-or anteiso-typQ and not isolated as a normal-type. 1>2) The synthetic strategy is shown in Fig. 1 . Also as to determine the stereochemistry of the natural products, two epimers in the /3-position of the (5AA moiety should be synthesized. The synthetic procedure was planned to obtain racemic /?AA.
The racemic /3AA and L-Val will be coupled and the resulting dipeptides (abbreviated as segment-A) will be obtained as a mixture of two diastereomers. The diastereomers should be separated to obtain two optically pure segment-As. The another dipeptide (abbreviated as segment-B) will be obtained with Gly and L-Lys.
One of the diastereomers of segment-A will be coupled In the final step C-terminus of /3AA and Af-terminus of Gly will be coupled to cyclize the linear tetrapeptide. The reasons of the ring closure with that position were considered with the next two points: (i) minimumsteric hindrance will cause high flexibility of the molecule; (ii) racemization at the coupling site will be out of consideration. Synthesis of n-Cn-fiAA was planned as follows. Wittig reaction to an aldehyde,^-decanal (1) will give a,/?-unsaturated ester (2)3 4) and thermal Michael addition of an amine to this will be performed. was achieved by following the procedure shown in Scheme 1. Wittig reaction of^-decanal (1) with (carbomethoxymethylene)triphenylphosphorane gave trans-a,/3-unsaturated ester (2).3' 4)
The cw-compound (3) was gave as a byproduct and the ratio of2 to 3 were 16 to 1. Thermal Michael addition to trans-ester (2) was carried out by refluxing in EtOH for 22 hours with benzylamine to give 7V-Bzl-/3-amino ester (4)5' 6) in 43.0% yield. The starting material (2) was recovered in 45.4% yield. Debenzylation of 4 by using Pearlman's catalyst gave TV-free /3-amino ester (5)9' 10) almost quantitatively. Coupling of 5 with Boc-L-Val (6) by using l -(3-dimethylaminopropyl)-3-ethylcar-Scheme 1. Synthetic route of(^)-segment-A, TFA salt (8a).
bodiimide hydrochloride (abbreviated as WSCHC1) as a coupling reagent gave the crude dipeptide, segment-A (7) in 90.5% yield. Crystallization differentiation (^-hexaneEtOAc) of the mixture of the diastereomers (7) gave the one diastereomer (called as (7?)-segment-A) (7a) as colorless crystals in 26.5% yield. The residue containing the other (called as (^-segment-A) (7b) as a main product was obtained in 51.6% yield (Scheme 1). 7a and 7b were indistinguishable on TLC analysis, but could be distinguished by means of *H NMRspectrometry. The stereochemistry of /J-position of n-Cl2-(3AA in 7a was determined (R) by comparison of the values of optical rotation, which was measured with n-C\2-/3AA obtained from 7a by acid hydrolysis (6n HC1, 150°C, 8 hours), and with those of (^)-3-aminooctanoic acid and (R)-3-aminodecanoic acid described in the literatures11>12): by coupling reaction of Boc-Gly (15) to L-Lys(Z)-OMeà" HC1 (16) by using triethylamine and WSCà" HC1. The prepared two dipeptide segments were coupled to provide the tetrapeptide. First, alkaline hydrolysis of ester of 17 gave the free acid (9) in 93.3% yield. On the other hand, deprotection of (R)-segment-A (7a) by using TFA gave the TFAsalt (8a)13) almost quantitatively.
Coupling reaction of9 to 8a by using WSC-HC1, 1-hydroxybenzotriazole (abbreviated as HOBt) and triethylamine gave the protected tetrapeptide (10a)13) in 93.6% yield. Alkaline hydrolysis of ester of 10a in THF/MeOH/ H2O (3: 1 : 1) byusing 0.1m LiOH H2O gave the free acid (lla)14) in 86.6% yield. Then deprotection of lla in TFA/ CH2C12 (1 : 1) stirring in an ice bath gave the tetrapeptide TFAsalt (12a) almost quantitatively. Cyclization of 12a in DMFby using diphenylphosphoryl azide (abbreviated as DPPA) and NaHCO3gave the crude product (13a).14 15) Sequential debenzyloxycarbonylation of 13a in TFA by catalytic reduction over 10% Pd/G gave the crude desired product quantitatively though the reaction was slow. After purification of this crude product by preparative HPLC, cyclo (-Gly-L-Lys-L-Val-(7?)-3-aminododecanoyl-) (named as LV9nA) (14a) was obtained (Scheme 2). In the same way the synthesis using the protected (S)-segment-A (8b) that was the diastereomer of 8a gave cyclo
Scheme 2, Synthetic route ofLV9nA (14a). that the stereochemistry of /3-position of /?AA moiety in natural rhodopeptins was (R).
Wewill describe the structure-activity relationship of rhodopeptin derivatives on the basis of the obtained synthetic procedure mentioned above elsewhere. AUG. 1999 Experimental
General
The mp was measured with a Yanagimoto micro-mp apparatus and is uncorrected. FAB-MS was obtained on a Jeol JMS-SX102Aspectrometer. JH and 13C NMRspectra were recorded on a Jeol JNM-GSX400 spectrometer at 400 MHz (Merck). The products were detected by ninhydrin reagent at 120°C. Preparative HPLC was performed by using TSKgel ODS-120T column (Tosoh, 55X300mm) with UV detection at 210nmand a flow rate of 50ml/minute. Solvent systems are indicated in each case.
Methyl (£)-Dodec-2-enoate (2) A suspension of (carbomethoxymethylene)triphenylphosphorane (7.36 g, 1.1 equiv) in benzene (60 ml) was stirred at room temperature under a nitrogen atmosphere. A solution of^-decanal (1) (3.13 g, 20mmol) in benzene (10 ml) was added dropwise to this suspension. The mixture was refluxed for 7 hours, cooled to room temperature, and evaporated. The solid residue was suspended with «-hexane and allowed to stand at room temperature overnight. After filtration of the precipitate, the filtrate was evaporated to give the residue (4.92 g). This was chromatographed on silica gel (150g) using ft-hexane-toluene (4 : 1-2 : 1) to give c/s-ester (3) (188.4mg, yield 4.4%) as an oil, and using nhexane-toluene (2 : 1-1 : 1) to give trans-ostQV (2) C(3)); Rf0.5 («-hexane-toluene, 1 : 1). 3: IR (neat) cm "1 2926, 2855, 1728, 1645, 1439, 1408, 1314, 1198, 1175, 1019, 818, 723 ; !H NMR (CDC13) 5 0.88 (3H, t, 7=7.0Hz, C(12)), 1.26 (12H, brs, C(5)~(10)), 1.45 (2H, m, C(ll)), 2.64 (2H, ddd, 7=15.0, 7.7, 1.8Hz,
Methyl 3 -7V-Benzylaminododecanoate (4) Benzylamine (76.3 ml, 1.0 equiv) was added to a solution of trans-ester (2) (148.1 mg, 0.70mmol) in EtOH (5ml).
The mixture was refluxed for 5 hours under a nitrogen atmosphere. After addition of benzylamine (1.0 equiv), this solution was refluxed again for 17 hours under a nitrogen atmosphere, cooled to roomtemperature, and evaporated to
give the residue (266.8mg).
The residue was chromatographed on silica gel (13.5 g) using n-hexane -toluene Boc-L-Val-3-aminododecanoic Acid Methyl Ester (7) A solution of5 (633.1 mg, 2.77mmol) and 6 (696.4 mg, 1.1 equiv) in CH2C12 (15ml) was stirred at -20°C under a nitrogen atmosphere. A solution of WSC-HC1(583.0mg, 1.1 equiv) in CH2C12 (10ml) was added dropwise to this solution. The mixture was stirred at -20°C for 80 minutes and at room temperature for 3 hours. The mixture was cooled to -20°C again, and a solution of WSC.-HC1 (212.0mg, 0.4equiv) in CH2C12 (5 ml) was added dropwise to the mixture. The mixture was stirred at -20°C for 1 hour, and was further stirred for 15 hours allowing to warm to room temperature. The solution was diluted with CH2C12, washed sequentially with cold 0.1 n HC1, cold satd aq NaHCO3,water (twice), and satd aq NaCl, dried over Na2SO4, and evaporated to give crude 7 (1.07g, yield 90.5%). This was recrystallized from Ti-hexane -EtOAc by standing overnight at 5°G. The crystals were collected, washed with^-hexane, and dried. The pure (i^)-segment-A (7a) 257.5 mg (21.8%) was obtained as colorless crystals. The filtrate was evaporated to give the residue (933.9mg). This was chromatographed on silica gel (45g) using toluene -EtOAc (5 : 1) to give the mixture of diastereomers (7) Boc-Gly-L-Lys(Z)
One n NaOH(3.38ml, 1.1 equiv) was added dropwise to a stirred ice-cooled solution of 17 (1.39g, 3.08mmol) in MeOH(34ml). The mixture was stirred for 6.5 hours at room temperature and evaporated. After addition of water and ether to the residue, this was suspended. The aqueous layer was separated from this suspension, cooled in an ice bath, acidified to pH 4 with 0.1 N HC1, and extracted three times with EtOAc. The EtOAcextracts were washed sequentially with water and satd aq NaCl, dried over Na2SO4, and evaporated to give crude 9 (1.25g, yield 93.3%). This was used in the next reaction without further purification: 
Boc-Gly-L-Lys(Z)-L-Val-3(i?)-aminododecanoic Acid
Methyl Ester (10a) Triethylamine (249 ml, 3.0 equiv) was added to a stirred solution of 8a (263.0mg, 0.595mmol) in THF (20ml) at -5°C under a nitrogen atmosphere. After the dropwise ad-717 dition of a solution of 9 (312.0mg, 1.2equiv) in THF (10ml) to the mixture, HOBt (120.6mg, 1.5equiv) and WSCHC1 (171.1mg, 1.5equiv) were also added to the mixture successively at -5°C under a nitrogen atmosphere. The mixture was stirred at -5°C for 75 minutes and at room temperature for 1.5 hours. After removal of the solvent, the residue was dissolved in water and EtOAc. The EtOAclayer was separated from this suspension, washed sequentially with 1 n HC1, satd aq NaHCO3, water (twice), and satd aq NaCl, dried over Na2SO4, and evaporated to give 10a (416.1 mg, yield 93.6%) as a white powder. This was used in the next reaction without further purification: mp 150~152°C; FAB-MS (Matrix; NBA) positive m/z 748 
The protected tetrapeptide (10a) (415.3 mg, 0.556 mmol) was dissolved in 0.1M LiOH THF-MeOH-H2O(3: 1 : 1) soln (15 ml). This solution was stirred for 5 hours at room temperature. After addition of 0.1 n HC1 (15ml) to this solution in an ice bath, water and EtOAc were added to the mixture. The mixture was shaken and then the EtOAclayer was separated from that suspension. The aqueous layer was further extracted with EtOAc and CHC13successively. The combined EtOAcextracts and the CHC13extracts were respectively washed with satd aq NaCI, dried over Na2SO4, and evaporated together to give the crude product (391.2 mg). This was chromatographed on silica gel (20g) with CHCl3-MeOH (10: 1-5: 1) 
After the dropwise addition of TFA(15 ml) to a stirred ice-cooled suspension of lla (341.7mg, 0.466mmol) in CH2C12(15ml), the mixture was stirred at room temperature for 35 minutes, and evaporated. The residue was coevaporated with toluene and MeOHsuccessively to give 12a (376.8mg) almost quantitatively as a white powder. 
A degassed solution of 12a (336.7mg, 0.451 mmol) in DMF (50ml) was stirred in an ice bath. NaHCO3 (189.3 mg, 5.0equiv) was added to this solution and DPPA(146 ml, 1.5 equiv) was successively added dropwise to the mixture in an ice bath. This was stirred for 1 hour in an ice bath, 18.5 hours at 10~15°C, and then 7 hours at room temperature under a nitrogen atmosphere. This was cooled in an ice bath again, and the precipitate was obtained by addition of water to this mixture. The precipitate was col- AUG. 1999 lected and dried to give crude 13a (313. cyclo (-Gly-L-Lys-L-Val-3 (i?)-aminododecanoyl-) (14a) A catalytic amount of 10% Pd-C (2 spatulas) was added to a solution of 13a (290.8mg, 0.473 mmol) in TFA (6 ml). The mixture was vigorously stirred under a hydrogen atmosphere for 3 hours at room temperature. After addition of 10% Pd-C (1 spatula) to the mixture, this was hydrogenated again for additional 1 hour. After filtration of the catalyst, the filtrate was evaporated. The above hydrogenation and workup were repeated twice with the obtained residue for 7 hours and 3.3 hours to give crude 14a as TFA salt (277.2 mg, yield 98.5%). Crude 14a (250mg) -17.6°(c 0.14, MeOH). Salt (8b) TFA (4 ml) was added dropwise to a stirred ice-cold solution of the solid residue containing 7b mainly (598.9 mg, 1.40mmol) in CH2C12(4ml). The mixture was stirred in an ice bath for 40 minutes and at room temperature for additional 40 minutes. After removal of the solvent, the solid residue was coevaporated with toluene (twice) and CHC13 to give crude 8 (775 mg). This was chromatographed on silica gel (40g) using CHCl3-MeOH (50: 1-10: 1} to give TFA salt (8b) (443.1 mg, yield 71.6%) as an oil, and using cyclo (-Gly-L-Lys-L-Val-3 (£)-aminododecanoyl-) (14b) A catalytic amount (2 spatulas) of 10%Pd-C was added to a solution of 13b (357.2mg, 0.58mmol) in TFA (9ml). The mixture was vigorously stirred under a hydrogen atmosphere for 6 hours at room temperature. After filtration of the catalyst, filtrate was evaporated. This hydrogenation was repeated with the obtained residue for 7 hours to give crude 14b as TFA salt (456.1 mg). Crude 14b (440mg) was purified by preparative HPLC (eluent, 45% CH3CN -0.01 n HC1). The fraction containing the desired product (Rt 20 minutes) was combined, concentrated in vacuo, and lyophilized to give a white powder 14b (180mg, converted yield 62.1% from 13b) as HC1 salt: mp 250~255°C (dec); FAB-MS (Matrix; Glycerin) positive m/z 482 (M+H)+, 574 (M+H+Glycerin)+; IR (KBr) cm "1 3430, 3308, 3057, 2961, 2926, 2855, 1658 (br), 1545, 1468, 1425, 1335, 1289, 1246, 1208, 1182, 1132, 837, 801, 723, 683 
Biological Assay
The antifungal activities of 14a and 14b were determined by a two-fold micro-dilution method with Sabouraud-Dextrose broth after incubation 35°C for 48 hours.
